NASDAQ | TSX: ACB
Investment in the region continues with the launch of IndiMed, the company’s first locally grown brand in Germany
EDMONTON, AB, Jan. 23, 2025 /PRNewswire/ – Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora’s leading EU-GMP facility in Leuna, Germany, the new brand offers a supply of high-quality, locally grown and sold, medical cannabis for the country’s expanding patient base.
Investment in the region continues with the launch of IndiMed, the company’s first locally grown brand in Germany
EDMONTON, AB, Jan. 23, 2025 /PRNewswire/ – Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora’s leading EU-GMP facility in Leuna, Germany, the new brand offers a supply of high-quality, locally grown and sold, medical cannabis for the country’s expanding patient base.
